• ABOUT
  • THE GROUP
  • NEWS & MEDIA
  • EVENTS
  • CAREER
  • CONTACT US
  • 0
The Quintessential Accessory to NGS for CNV Screening: SALSA digital MLPA

The Quintessential Accessory to NGS for CNV Screening: SALSA digital MLPA

BY Nandini Pain 5th December 2020

A variant of multiplex polymerase chain reaction (PCR) is the multiplex ligation-dependent probe amplification (MLPA). In this technique only a single primer probe is used to amplify multiple targets. Using MLPA, copy number variations (CNV) are detected at a molecular level, and the analysis is done using the specific software program called Coffalyser.NET.
Selective Adaptor Ligation, Selective Amplification (SALSA)digitalMLPA runs on the same principle as a conventional MLPA but has a greater advantage of detecting many more targets. It’s the amalgamation of MLPA technology and Next-generation sequencing (NGS) for CNV detection for a larger number of targets.


With reduced costs and turnaround times, digitalMLPA can detect up to 1000DNA sequences in a simple multiplex PCR-based reaction. The PCR products or amplicons that are generated in the digitalMLPA can be quantified using Illumina NGS platforms. The read numbers of each digitalMLPA probe amplicon is determined by Sequencing.
The aim of digitalMLPA is to increase the efficiency of CNV screening. D001 Hereditary Cancer Panel 1, the first SALSA digitalMLPA panel by MRC-Holland, has greater gene coverage than that of ten conventional MLPA assays thus streamlining the oncogenetic screening process.


CNVs in 28 clinically relevant genes and six specific point mutations are detected by the digitalMLPA probemix D001. The hereditary predisposition to one or more of the following cancer types: breast, colorectal, gastric, ovarian, endometrial, prostrate, melanoma, and pancreatic depends on the mutation statuses of the aforementioned genes.


A single chip can be used to run digitalMLPA reactions and NGS libraries therefore making digitalMLPA the ideal time-saving accompaniment to NGS for high-level CNV screening.


Being the inventors and manufacturers of MLPA, digitalMLPA and Melt Assay, MRC-Holland aims to find simpler solutions to genetic inquiries. We at DSS Imagetech Pvt Ltd are honoured to bring both, SALSA MLPA and digitalMLPA, at your doorstep.


At DSS Imagetech Pvt Ltd we live by its motto i.e inspired by technology.

Nandini Pain

Assistant Manager - Sales, Clinical Diagnostics Division


An assistant manager in sales team for Clinical Diagnostic Division at DSS Imagetech Pvt Ltd. Currently responsible for generating sales for various consumables for Molecular Biology Labs and also lending support to customers in selecting the perfect solution for their labs. She has a Master of Science degree in Applied Microbiology from KIIT University, Bhubaneswar.

Latest Articles

Unlocking the Mysteries of the Immune System With Clonality Assays
BY Dr. Hitarth Patel 22nd January 2025

The immune system is an extraordinary defense mechanism, safeguarding our bodies against a multitude of threats. Its capacity to discriminate between self and non-self is essential for preserving health in the face of infections and cancer. When the balance within the immune system is disturbed, it can lead to various dysfunctions with serious implications. In […]
Read more

Advancements in Clonality Testing
BY Ms. Megha Dhumal 17th January 2025

The immune system, one of the most intricate networks in the human body, tirelessly protects us from pathogens such as bacteria, viruses, fungi, and more. While a healthy immune system ensures defense and health, any compromise can lead to diseases, autoimmune conditions, allergies, or even cancer. Clonality testing, a crucial advancement in hematologic oncology, has […]
Read more

The Role of Artificial Intelligence in Oncology Diagnostics: Enhancing Accuracy and Efficiency
BY DSS Imagetech Pvt Ltd 30th December 2024

The blending of artificial intelligence (AI) with medical research has paved the path for unprecedented improvements in cancer diagnoses. AI is revolutionizing the science of cancer detection by processing enormous volumes of data, seeing patterns, and making precise predictions. AI-powered technologies are giving physicians crucial tools to diagnose cancer early, customize treatment programs, and enhance […]
Read more

Sustainable Practices in Medical Device Manufacturing: Towards Greener Healthcare Solutions
BY DSS Imagetech Pvt Ltd 28th December 2024

The concept of sustainable healthcare is quite trending these days, especially because people are becoming more aware of their environment and responsibilities towards it. In a nutshell, sustainability in healthcare refers to the concept of fulfilling the healthcare needs of the current generation while ensuring that the economic, environmental, and social resources aren’t compromised for […]
Read more

Understanding Regulatory Compliance in Medical Device Development
BY DSS Imagetech Pvt Ltd 26th November 2024

Today’s healthcare system is far different from the traditional system used previously. There’s a strong involvement of technology in every aspect of it, especially due to the use of medical devices. A wide range of medical devices are used in today’s modern healthcare to diagnose and treat many diseases. For example, ultrasound and CT scans […]
Read more

The Role of Molecular Diagnostics in Enhancing Success Rates of IVF
BY DSS Imagetech Pvt Ltd 25th November 2024

Today’s advanced technology has a solution for everything. Infertility is one of those problems, which has been on the rise for the past few decades and may turn into a global health issue if strict measures aren’t taken. In vitro fertilization (IVF) is one of the effective solutions for infertility, in which sperm and eggs […]
Read more